第 1 到 15 筆結果,共 15 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2021 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial | Hsu Y.-C.; Chen C.-Y.; Chang I.-W.; Chang C.-Y.; Wu C.-Y.; Lee T.-Y.; MING-SHIANG WU ; Bair M.-J.; Chen J.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; Tai C.-M.; Huang Y.-T.; Ku W.-H.; Mo L.-R.; Lin J.-T. | The Lancet Infectious Diseases | 21 | 20 | |
2 | 2020 | Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus | JYH-MING LIOU ; Malfertheiner P.; YI-CHIA LEE ; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; MEI-JYH CHEN ; TSUNG-HSIEN CHIANG ; CHIEH-CHANG CHEN ; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; TZU-CHAN HONG ; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; MING-SHIANG WU ; El-Omar E.M. | Gut | 214 | 187 | |
3 | 2019 | Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk | Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; MING-SHIANG WU ; Yang T.-H.; CHIEH-CHANG CHEN ; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y. | Alimentary Pharmacology and Therapeutics | 69 | 62 | |
4 | 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; MEI-JYH CHEN ; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
5 | 2018 | Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection | MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YEN-NIEN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | American Journal of Gastroenterology | 31 | 25 | |
6 | 2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | MEI-JYH CHEN ; MING-SHIANG WU ; CHIEN-CHUAN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 21 | 20 | |
7 | 2017 | Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy | Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU ; Yang T.-H.; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. | Journal of Gastroenterology and Hepatology (Australia) | 12 | 11 | |
8 | 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 40 | 38 | |
9 | 2016 | Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients | Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU ; JIA-HORNG KAO ; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Hung H.-W.; Wu C.-Y.; Lin J.-T. | Clinical Gastroenterology and Hepatology | 40 | 33 | |
10 | 2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 62 | 59 | |
11 | 2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; MEI-JYH CHEN ; PING-HUEI TSENG ; CHIEN-CHUAN CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 66 | 51 | |
12 | 2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 65 | 63 | |
13 | 2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; YU-JEN FANG ; Lee J.-Y.; CHIEN-CHUAN CHEN ; SHIH-JER HSU ; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; LU-PING CHOW ; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 76 | 73 | |
14 | 2011 | Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; WANG-HUEI SHENG ; HSIU-PO WANG ; MING-SHIANG WU ; Lin J.-T. | Journal of Antimicrobial Chemotherapy | 40 | 40 | |
15 | 2005 | Lateral abdominal wall hematoma due to tear of internal abdominal oblique muscle in a patient under warfarin therapy | Tai C.-M.; KAO-LANG LIU ; CHIEH-CHANG CHEN ; Lin J.-T.; HSIU-PO WANG | American Journal of Emergency Medicine | 18 | 10 |